MBB Public Markets I LLC Makes New $632,000 Investment in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

MBB Public Markets I LLC acquired a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 52,285 shares of the pharmacy operator’s stock, valued at approximately $632,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Pineridge Advisors LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $26,000. 1832 Asset Management L.P. grew its holdings in shares of Walgreens Boots Alliance by 282.1% during the fourth quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 900 shares during the last quarter. New Covenant Trust Company N.A. bought a new stake in shares of Walgreens Boots Alliance during the first quarter worth about $35,000. Iron Horse Wealth Management LLC raised its holdings in shares of Walgreens Boots Alliance by 162.5% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 1,300 shares during the last quarter. Finally, FinTrust Capital Advisors LLC boosted its stake in Walgreens Boots Alliance by 60.4% during the 1st quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock valued at $46,000 after purchasing an additional 802 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $8.70 on Wednesday. Walgreens Boots Alliance, Inc. has a 52-week low of $8.22 and a 52-week high of $27.05. The stock’s 50-day simple moving average is $9.90 and its 200 day simple moving average is $14.07. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The stock has a market capitalization of $7.51 billion, a price-to-earnings ratio of -1.29, a price-to-earnings-growth ratio of 1.03 and a beta of 0.70.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $1.00 annualized dividend and a yield of 11.49%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Wall Street Analyst Weigh In

Several analysts have recently commented on WBA shares. Evercore ISI lowered their price objective on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating for the company in a research note on Friday, June 28th. Truist Financial dropped their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a research note on Friday, June 28th. Royal Bank of Canada reduced their target price on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research note on Tuesday, July 2nd. UBS Group dropped their price target on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 3rd. Finally, Barclays reduced their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a research report on Tuesday, July 23rd. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $14.73.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.